Arrowhead Research | ARWR - Market Capitalization


Arrowhead Research reported $11.1B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 10.84B 664M Aug/2026
Heron Therapeutics USD 238M 7M Dec/2025
Incyte USD 26.84B 4.19B Aug/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Ligand Pharmaceuticals USD 5.31B 1.02B Aug/2026
Merck USD 324.18B 6.81B Aug/2026
Nektar Therapeutics USD 12.98B 10.86B Aug/2026
Novartis USD 240.59B 67.17B Jun/2026
Sarepta Therapeutics USD 1.5B 402M Aug/2026
TG Therapeutics USD 7.63B 778M Aug/2026
Ultragenyx Pharmaceutical USD 2.12B 1.16B Aug/2026
Vertex Pharmaceuticals USD 137.33B 11.26B Aug/2026
Xencor USD 1.21B 19M Aug/2026